InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,464.62
(
-0.16%
)
US TECH 100
19,220.00
(
-0.20%
)
Dow Jones
39,150.33
(
0.04%
)
Brent Oil
84.14
(
0.14%
)
Bitcoin
63,052.09
(
-0.16%
)
Post# of 21373
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

DayDreeming

Send PM Follow Ignore
Followers 4
Posts 687
Boards Moderated 0
Alias Born 09/27/2016

DayDreeming

Re: None

Thursday, 01/03/2019 5:44:55 PM

Thursday, January 03, 2019 5:44:55 PM

Post# of 21373
When you look up "deception" in the future you will see a picture of Redman next to it. Injections were likely performed early 2018 and so the reactions happened quite soon after. Wonder if noteholders were aware of this BEFORE they renegotiated the notes long after that. Bet not. Wow!!!!!!

8K Dated November 29, 2018 (Released January 2, 2019)

Item 8.01 Other Events

"The Company is halting enrollment in its Phase I clinical trial of Prolanta for the treatment of ovarian cancer as a result of injection site reactions at the current dose level. No other adverse effects or signs of toxicity have been observed for the drug."

Death smiles on us all. All a man can do is smile back.

Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up